Gait Patterns After Intraarticular Treatment of Patients With Osteoarthritis of the Knee
Launched by PHILIPPS UNIVERSITY MARBURG · Aug 7, 2008
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Osteoarthritis (OA) is the most common chronic joint disease of the aging patient. The primarily affected joints are the knee and hip. The progress of the disease has an important influence on the patient´s life, including functional and social activities, body image and emotional well being. Furthermore, socioeconomic aspects play an eminent role in the treatment of osteoarthritis in joints.
In non-operative treatment, pain reduction and improved function are the primary goals. It is important to distinguish between systemic and local therapeutic options. In the systemic treatment, pallia...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • men and women between 35 and 80 years of age
- • radiographically verified degenerative osteoarthritis of the knee (grade II or III according to the Kellgren and Lawrence classification)
- • pain of at least 40 mm on a 100 mm visual analogue scale (VAS) at initial examination
- • persisting pain for at least 6 months
- • Lequesne-Score of at least 10 points
- • good physical and mental status
- • good compliance and agreement to participate in this study
- Exclusion Criteria:
- • non-degeneratively induced osteoarthritis
- • rheumatoid arthritis
- • ligamentous instability or complete resection of the meniscus
- • Sudeck´s disease
- • operations of the affected knee within the last three months
- • varus or valgus deformity of more than 15 degrees
- • patellofemoral arthritis
- • intraarticular therapy of the affected joint within the last 6 months with hyaluronan and three months with glucocorticoids
- • severe systemic diseases (tumor, exacerbated diabetes mellitus, hyperthyroidism)
- • anti-thrombotic medication or regular medication with NSAID/psychiatric pharmaceuticals
- • infectious diseases
- • alcohol abuse
- • drugs
- • psychiatric diseases or suicidal tendencies
- • involvement in another study
- • non-compliance
- • acute hemarthrosis or joint effusion
- • allergic predisposition
- • skin infections or skin diseases around the knee
About Philipps University Marburg
Philipps University Marburg, established in 1527, is one of Germany's oldest universities and a leading institution in research and education. Known for its commitment to advancing medical science, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes. With a focus on innovative therapies and interdisciplinary collaboration, Philipps University Marburg leverages its expertise in various medical fields to contribute to cutting-edge research and the development of new treatment modalities. Its robust infrastructure and dedication to ethical research practices ensure the integrity and efficacy of its clinical studies, making it a pivotal player in the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Muenster, , Germany
Patients applied
Trial Officials
Susanne Fuchs-Winkelmann, Prof. MD
Study Chair
University Hospital Marburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials